Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Alveolar ridge preservation after removing upper back molars

Official title: Alveolar Ridge Preservation (ARP) in the Posterior Maxilla: A Clinical and Economic Evaluation of ARP After the Extraction of Maxillary Molars

Run by Virginia Commonwealth University · NCT07433322 · Data updated 2026-11-12

This test compares placing an Ossix mineralized graft immediately after an upper molar extraction versus waiting to graft at implant placement to see if immediate grafting better preserves bone for future dental implants.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorVirginia Commonwealth University
Academic / other
Locations1 site (Richmond, Virginia)
StatusRecruiting
StartedJune 18, 2026
Main results expectedMarch 2028
Study endsApril 2028
Registry record updatedAugust 20, 2026
Trial IDNCT07433322 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a maxillary molar indicated for extraction who have at least 6 mm residual bone height, intact or ≤5 mm buccal/palatal dehiscence, and who are medically fit and not heavy smokers are ideal candidates.

Probably not a fit

Patients who are medically compromised, heavy smokers, under 18, or who have insufficient residual bone height (<6 mm) or large dehiscences (>5 mm) are unlikely to benefit from the interventions tested here.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional protocol enrolls adults who need extraction of a maxillary molar and who have at least 6 mm of residual bone height and minimal buccal/palatal defects (<5 mm). Participants receive either an immediate Ossix mineralized graft at the time of extraction or delayed grafting at the time of implant placement, with coordinated prosthetic and surgical planning using digital workflows. The multidisciplinary team from periodontics and prosthodontics will follow patients longitudinally to measure horizontal and vertical ridge dimensions, record need for additional grafting, and document implant positioning outcomes. Outcomes will focus on preservation of ridge height/width, need for supplemental procedures, and implant readiness.

Why it matters

Potential benefit: If successful, this approach could preserve more bone after extraction and reduce the number of grafting procedures needed before implant placement.

How similar studies have gone: Alveolar ridge preservation techniques have been shown in multiple studies to reduce post-extraction horizontal and vertical bone loss, though outcomes in the posterior maxilla with sinus-related changes remain more challenging and variably reported.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Intact or \<5mm dehiscence buccally and palatally
* Initial residual bone height (RBH) of at least 6 mm. 3-A minimum distance of 1 mm between root apices and sinus membrane.

Exclusion Criteria

* Medically compromised
* heavy smokers
* young (\<18 yrs.) or those refusing treatment are excluded.

Where it's running

  • Virginia Commonwealth University
    Richmond, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Iya Ghassib — Virginia Commonwealth University
  • Study coordinator: Iya Ghassib
  • Email: ghassibi@vcu.edu
  • Phone: (804) 628-8376

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.